Urban legends: pemphigus vulgaris

作者: N Cirillo , E Cozzani , M Carrozzo , SA Grando

DOI: 10.1111/J.1601-0825.2011.01899.X

关键词:

摘要: Pemphigus vulgaris (PV) is the most common type of pemphigus. PV pathogenesis still debated, and treatment remains challenging. We investigated five controversial topics: (1) What are target antigens in PV? (2) Do desmogleins adequately address pathophysiology? (3) How does acantholysis occur (4) Is a lethal disease? (5) role rituximab (RTX) treatment? Results from extensive literature searches suggested following: Target include variety molecules receptors that not physically compartmentalized within epidermis. caused by autoantibodies to keratinocyte self-antigens, which concur cause blistering acting synergistically. The concept apoptolysis distinguishes unique mechanism autoantibody-induced damage other known forms cell death. potentially life-threatening largely because side effects, but it uncertain therapies carry highest likelihood risk. RTX very promising option patients with widespread recalcitrant or PV. RTX's cost an issue, its long-term effects unknown, randomized controlled trials needed establish optimal dosing regimen.

参考文章(189)
Paco Hulpiau, Frans van Roy, Molecular evolution of the cadherin superfamily The International Journal of Biochemistry & Cell Biology. ,vol. 41, pp. 349- 369 ,(2009) , 10.1016/J.BIOCEL.2008.09.027
Yukari Yamamoto, Yumi Aoyama, En Shu, Kazuyuki Tsunoda, Masayuki Amagai, Yasuo Kitajima, Anti-desmoglein 3 (Dsg3) Monoclonal Antibodies Deplete Desmosomes of Dsg3 and Differ in Their Dsg3-depleting Activities Related to Pathogenicity Journal of Biological Chemistry. ,vol. 282, pp. 17866- 17876 ,(2007) , 10.1074/JBC.M607963200
Hakan M. Gürcan, Derin B. Keskin, Joel N.H. Stern, Matthew A. Nitzberg, Haris Shekhani, A. Razzaque Ahmed, A review of the current use of rituximab in autoimmune diseases. International Immunopharmacology. ,vol. 9, pp. 10- 25 ,(2009) , 10.1016/J.INTIMP.2008.10.004
Vu Thuong Nguyen, Juan Arredondo, Alexander I Chernyavsky, Yasuo Kitajima, Mark Pittelkow, Sergei A Grando, None, Pemphigus Vulgaris IgG and Methylprednisolone Exhibit Reciprocal Effects on Keratinocytes Journal of Biological Chemistry. ,vol. 279, pp. 2135- 2146 ,(2004) , 10.1074/JBC.M309000200
Zhi Liu, Ning Li, Luis A. Diaz, Inhibition of pemphigus vulgaris by targeting of the CD40-CD154 co-stimulatory pathway: a step toward antigen-specific therapy? Journal of Investigative Dermatology. ,vol. 126, pp. 11- 13 ,(2006) , 10.1038/SJ.JID.5700059
Sergei A Grando, Vivian T Laquer, Hai M Le, None, Sirolimus for acute pemphigus vulgaris: A case report and discussion of dualistic action providing for both immunosuppression and keratinocyte protection Journal of The American Academy of Dermatology. ,vol. 65, pp. 684- 686 ,(2011) , 10.1016/J.JAAD.2011.01.029
Sergei A Grando, None, Autoimmunity to keratinocyte acetylcholine receptors in pemphigus. Dermatology. ,vol. 201, pp. 290- 295 ,(2000) , 10.1159/000051540
Debabrita Deb-Basu, Eiman Aleem, Philipp Kaldis, Dean W. Felsher, CDK2 is required by MYC to induce apoptosis. Cell Cycle. ,vol. 5, pp. 1342- 1347 ,(2006) , 10.4161/CC.5.12.2859
Enno Schmidt, Kirsten Hennig, Christian Mengede, Detlef Zillikens, Arno Kromminga, Immunogenicity of rituximab in patients with severe pemphigus. Clinical Immunology. ,vol. 132, pp. 334- 341 ,(2009) , 10.1016/J.CLIM.2009.05.007